The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
Results from year two of the pivotal Phase 3 KITE clinical trial reaffirmed visual acuity gains and fluid reduction findings as well as safety profile from year one
Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes
Launches FSSAI’s inclusive campaign to stop obesity with multilingual, sign language outreach and multi-platform media engagement under Eat Right India programme
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Approximately 35% of male cancer patients and 12% of female cancer patients at Paras Health were diagnosed with tobacco-related cancers
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
Standalone profit from operations for the quarter were Rs. 162 crores
Subscribe To Our Newsletter & Stay Updated
